U.S./EU MRA
This article was originally published in The Gray Sheet
Executive Summary
FDA go-ahead for three additional EU CABs is anticipated in the next month, the agency indicates. Final confirmation will allow the CABs to perform select independent premarket reviews and quality systems inspections under the U.S./EU mutual recognition agreement. In January, the UK's SGS Yarsley became the first CAB to gain FDA confirmation. The confidence-building phase of the MRA, likely to be extended by two years, is expected to be among topics discussed at an upcoming March 14 MRA stakeholder teleconference. The MRA confidence building phase was originally slated to end in December 2001(1"The Gray Sheet" Nov. 26, 2001, p. 13)...
You may also be interested in...
U.S./EU MRA Seek Resolution To “Confidence-Building” Extension Dispute
The joint committee for the U.S./EU mutual recognition agreement will decide at its Nov. 30 meeting how much further to extend the confidence-building phase of the MRA medical device annex
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.